chr1-92263676-CA-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PVS1PP5_ModerateBS2_Supporting
The NM_053274.3(GLMN):βc.1355delβ(p.Leu452TrpfsTer24) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000997 in 1,604,588 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000013 ( 0 hom., cov: 33)
Exomes π: 0.0000096 ( 0 hom. )
Consequence
GLMN
NM_053274.3 frameshift
NM_053274.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.89
Genes affected
GLMN (HGNC:14373): (glomulin, FKBP associated protein) This gene encodes a phosphorylated protein that is a member of a Skp1-Cullin-F-box-like complex. The protein is essential for normal development of the vasculature and mutations in this gene have been associated with glomuvenous malformations, also called glomangiomas. Multiple splice variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 1-92263676-CA-C is Pathogenic according to our data. Variant chr1-92263676-CA-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 667407.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 14 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLMN | NM_053274.3 | c.1355del | p.Leu452TrpfsTer24 | frameshift_variant | 15/19 | ENST00000370360.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLMN | ENST00000370360.8 | c.1355del | p.Leu452TrpfsTer24 | frameshift_variant | 15/19 | 1 | NM_053274.3 | P1 | |
GLMN | ENST00000495106.5 | c.*16del | 3_prime_UTR_variant, NMD_transcript_variant | 14/18 | 1 | ||||
GLMN | ENST00000495852.6 | c.578del | p.Leu193TrpfsTer24 | frameshift_variant | 7/10 | 5 | |||
GLMN | ENST00000463560.1 | c.618del | p.Leu207TrpfsTer24 | frameshift_variant | 8/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152088
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251426Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135884
GnomAD3 exomes
AF:
AC:
4
AN:
251426
Hom.:
AF XY:
AC XY:
3
AN XY:
135884
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000964 AC: 14AN: 1452500Hom.: 0 Cov.: 27 AF XY: 0.00000829 AC XY: 6AN XY: 723378
GnomAD4 exome
AF:
AC:
14
AN:
1452500
Hom.:
Cov.:
27
AF XY:
AC XY:
6
AN XY:
723378
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74296
GnomAD4 genome
AF:
AC:
2
AN:
152088
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74296
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Glomuvenous malformation Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 22, 2018 | The p.Leu425TrpfsX24 variant in GLMN has been reported in one individual with gl omuvenous malformations and segregated with disease in at least 5 affected famil y members (Brouillard 2002). It has also been identified in 0.004% (4/111662) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad. broadinstitute.org). This variant is predicted to cause a frameshift, which alte rs the protein?s amino acid sequence beginning at position 452 and leads to a pr emature termination codon 24 amino acids downstream. This alteration is then pre dicted to lead to a truncated or absent protein. Loss of function of the GLMN ge ne is an established disease mechanism in autosomal dominant glomuvenous malform ation. In summary, although additional studies are required to fully establish i ts clinical significance, the p.Leu425TrpfsX24 variant is likely pathogenic. ACM G/AMP Criteria applied: PVS1, PP1_Moderate. - |
GLMN-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 02, 2024 | The GLMN c.1355delT variant is predicted to result in a frameshift and premature protein termination (p.Leu452Trpfs*24). This variant was reported in one family with 6 affected individuals with glomuvenous malformations (Brouillard et al 2002. PubMed ID: 11845407). This variant is reported in 0.0035% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/). Frameshift variants in GLMN are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at